Drug delivery systems using Virus-like Particles (VLPs) and nanostructures, such as those from Human Papillomavirus (HPV) and bacteriophages, can be functionalized with ligands targeting human cancer cell surface receptors to achieve targeted drug delivery to cancer cells [45,59]. This evidence concerns the gene CD177 and cancer.